Mangalam Drugs defaults on loans worth Rs 15.56 cr to two banks

Loan NpaCredit & Debt View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹47.00

prior close

₹49.35

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+6.3% vs market

Pharmaceuticals peers, median of 158sector-0.8%+5.8% vs sector

On the reaction day the stock moved 6.3 pts more than Nifty Microcap 250 and 5.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0-1.3+6.3-0.8+5.8

Next day

+10.2-4.0+14.2-3.1+13.4

+4.7-4.8+9.5-4.1+8.8

-0.5-3.3+2.8-3.0+2.5

-5.5-5.3-0.1-4.3-1.1

-10.2-5.2-5.0-4.6-5.6

-18.9-3.7-15.3-4.0-14.9

15d

-28.7+3.6-32.3-1.1-27.6

-32.5+0.1-32.7-2.4-30.1

-34.5-8.9-25.6-9.4-25.1

-37.7+3.2-40.9-1.0-36.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs has disclosed default on cash credit accounts with Bank of Maharashtra (Rs 10.41 crore overdue since Oct 17, 2025) and Bank of Baroda (Rs 5.15 crore overdue since Oct 20, 2025), totalling about Rs 15.56 crore. The default has continued for over 30 days. This is a subsequent disclosure to an earlier filing dated Dec 19, 2025. The company states it is arranging to pay the overdue amount soon.

Likely market impact

Loan default signals financial stress and possible NPA classification. Negative for stock and future credit availability.